SEC 13F Intelligence

Omega Fund Management, LLC / BCAX

Omega Fund Management, LLC’s Bicara Therapeutics Inc Position

Does Omega Fund Management, LLC own Bicara Therapeutics Inc (BCAX)? Yes — 2.39M shares worth $48M (+29.16% of its 13F portfolio) as of Q1 2026, up from 2.20M shares the prior filed quarter.

Position Value
$48M
Q1 2026
Shares
2.39M
% of Portfolio
+29.16%
Quarters Held
7
currently held

Position History BCAX

Reported value by quarter
Q3 ’24: $56MQ3 ’24Q4 ’24: $38MQ4 ’24Q1 ’25: $29MQ1 ’25Q2 ’25: $20MQ2 ’25Q3 ’25: $35MQ3 ’25Q4 ’25: $37MQ4 ’25Q1 ’26: $48MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.39M$48M+29.16%
Q4 20252.20M$37M+12.95%
Q3 20252.20M$35M+15.66%
Q2 20252.20M$20M+13.26%
Q1 20252.20M$29M+16.95%
Q4 20242.20M$38M+31.82%
Q3 20242.20M$56M+35.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Omega Fund Management, LLC’s full portfolio or all institutional holders of BCAX.